Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist

European Journal of Pharmacology

Volumn 323, Issue 1, 1997, Pages 27-36

  Smith, Hilary P ^a   Nichols, David E ^b   Mailman, Richard B ^a   Lawler, Cindy P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Dihydrexidine; Dopamine D2 receptor; Locomotor activity; Sedation; Vacuous chewing; Yawning

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DIHYDREXIDINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE AUTORECEPTOR; N,N PROPYLDIHYDREXIDINE; REMOXIPRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; GROOMING; LOCOMOTION; MALE; MASTICATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SNIFFING; SUBCUTANEOUS DRUG ADMINISTRATION; YAWNING;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADRENERGIC ALPHA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; COMPUTER SIMULATION; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; IDAZOXAN; LOCOMOTION; MALE; MASTICATION; PHENANTHRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REFERENCE STANDARDS; REMOXIPRIDE; STEREOISOMERISM; YAWNING;

EID: 0031003929     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00026-5     Document Type: Article

References (41)

1. 1 full agonist, J. Med. Chem. 33, 1756.
2. Brown, M.B. and A.B. Forsythe, 1951, The ANOVA and multiple comparisons for data with heterogeneous variances, Biometrics 30, 719.
3. Cohen, J., 1960, A coefficient of agreement for nominal scales, Educ. Psychol. Measur. 20, 37.
4. Costall, B., S.K. Lim and R.J. Naylor, 1981, Characterization of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice, Eur. J. Pharmacol. 73, 175.
5. 2-like' agonists, Neuropharmacology 32, 509.
6. Daly, S.A. and J.L. Waddington, 1993b, Behavioural evidence for 'D-1-like' dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C, Psychopharmacology 113, 45.
7. 3 receptor ligand, Eur. J. Pharmacol. 249, R9.
8. DiChiara, G., M.L. Proceddu, L. Vargiu, A. Argiolas and G.L. Gessa, 1976, Evidence for dopamine receptors mediating sedation in the mouse brain, Nature 264, 564.
9. Dohlman, H.G., M.G. Caron and R.J. Lefkowitz, 1987, A family of receptors coupled to guanine nucleotide regulatory proteins, Biochemistry 26, 2657.
10. 2 receptor agonist-induced behavioural effects in rats, Eur. J. Pharmacol. 250, 51.
11. Garau, L., S. Govoni, E. Stefanini, M. Trabucchi and P.P. Spano, 1978, Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum, Life Sci. 23, 1745.
12. Gingrich, J.A. and M.G. Caron, 1993, Recent advances in the molecular biology of dopamine receptors, Annu. Rev. Neurosci. 16, 299.
13. Gower, A.J., H.H.G. Berendsen, M.M. Princen and C.L.E. Broekkamp, 1984, The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity, Eur. J. Pharmacol. 103, 81.
14. Hjorth, S., A. Carlsson, H. Wikstrom, P. Lindberg, D. Sanchez, U. Hacksell, L.E. Arvidsson, U. Svensson and J.L. Nilsson, 1981, 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors, Life Sci. 28, 1225.
15. 2 agonist on oral movements in rats, Eur. J. Pharmacol. 134, 83.
16. 2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence, Life Sci. 43, 515.
17. Kebabian, J.W. and D.B. Calne, 1979, Multiple receptors for dopamine, Nature 227, 93.
18. 1 dopamine receptor agonist, J. Med. Chem. 37, 2453.
19. 3 receptor sites in rat brain: a comparative study using in situ hybridization histochemistry and ligand binding autoradiography, Eur. J. Neurosci. 5, 145.
20. Lewis, M.H., A.A. Baumeister, D.L. McCorkle and R.B. Mailman, 1985, A computer-supported method for analyzing behavioral observations: studies with stereotypy, Psychopharmacology 85, 204.
21. 1 receptor agonist, Eur. J. Pharmacol. 166, 111.
22. 2 agonist RU 24213 in young compared with aged rats, Br. J. Pharmacol. 95, 335.
23. Morelli, M., R. Longoni, L. Spina and G. DiChiara, 1986, Antagonism of apomorphine-induced yawning by SCH23390: evidence against the autoreceptor hypothesis, Psychopharmacology 89, 259.
24. 1 dopamine receptor agonist, J. Pharmacol. Exp. Ther. 262, 383.
25. Nisoli, E., C. Tonello, R. Imhof, R. Scherschlicht, M. Da Prada and M.O. Carruba, 1993, Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist, J. Pharmacol. Exp. Ther. 266, 97.
26. Pugsley, T.A., C.L. Christofferson, A. Corbin, H.A. DeWald, S. Demattos, L.T. Meltzer, S.L. Myers, Y.-H. Shih, S.Z. Whetzel, J.N. Wiley, L.D. Wise and T.G. Heffner, 1992, Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist, J. Pharmacol. Exp. Ther. 263, 1147.
27. 1 stimulation, Life Sci. 33, 2479.
28. 1 mediated oral dyskinesia in rats, Life Sci. 39, 29.
29. 1 receptors mediate repetitive jaw movements in rats, Pharmacol. Biochem. Behav. 45, 921.
30. Skirboll, L.R., A.A. Grace and B.S. Bunney, 1979, Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists, Science 206, 80.
31. Ståhle, L., 1992, Do autoreceptors mediate dopamine agonist-induced yawning and suppression of exploration? A critical review, Psychopharmacology 106, 1.
32. Ståhle, L. and U. Ungerstedt, 1987, Reduction of extracellular dopamine levels can be dissociated from suppression of exploratory behaviour in rats, Acta Physiol. Scand. 130, 533.
33. Strömbom, U., 1976, Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain, Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 167.
34. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release, J. Neural Transm. 95, 71.
35. Waddington, J.L., 1990, Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology, and putative relationship to tardive dyskinesia, Psychopharmacology 101, 431.
36. Walters, J.R. and R.H. Roth, 1976, Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 296, 5.
37. 3 receptor: a postsynaptic receptor inhibitory on rat locomotor activity, J. Neural Transm. 94, 11.
38. 3 receptor ligands, Eur. J. Pharmacol. 239, 271.
39. Welch, B.L., 1938, The significance of the differences between two means when the population variances are unequal, Biometrika 29, 350.
40. 3H-dopamine by slices of rat striatum, Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 279.
41. 2 receptors in yawning behavior in rats, Psychopharmacology 90, 9.